DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
34 hedge funds and large institutions have $1.98M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
Holders
34
Holders Change
-6
Holders Change %
-15%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
6
Closed
8
Calls
$130K
Puts
–
Net Calls
+$130K
Net Calls Change
+$41K
Top Buyers
| 1 |
1
Walleye Capital
New York
|
$405K |
| 2 |
LP
2
LMR Partners
London,
United Kingdom
|
$458K |
| 3 |
3
Walleye Trading
New York
|
$40K |
| 4 |
CAC
4
Cowen and Company
New York
|
$67.6K |
| 5 |
LOAMU
5
Lombard Odier Asset Management (USA)
New York
|
$6.56K |
